The EV1000 clinical platform from Edwards Lifesciences presents the physiologic status of the patient in an intuitive and meaningful way. Designed in collaboration with and validated by clinicians, the EV1000 clinical platform offers you scalability and adaptability for both the OR and ICU.
The EV1000 clinical platform enables you to choose the parameters needed to monitor your patients and may be used with a variety of Edwards advanced hemodynamic monitoring tools for an integrated Edwards Critical Care System.
The platform may be used with the Edwards advanced hemodynamic monitoring portfolio including the ClearSight finger cuff, FloTrac sensor, Edwards oximetry central venous catheter and PediaSat oximetry catheters and VolumeView set.
Based on the complexity of each procedure, and patient risk factors, choose
The EV1000 clinical platform provides the choice of the parameters you want to view and how you want to view them. Screen options include the real-time physiology screen (both intermittent and continuous), the cockpit screen, the goal positioning screen, graphical trend screen and the physio-relationship screen.Visual clinical support.
Continuous access to advanced hemodynamic parameters offers immediate insight into patient physiologic status, giving you the clarity to make more informed volume administration decisions to help you consistently maintain your patients in the optimal volume range. Color-based indicators communicate patient status at a glance, and visual clinical support screens allow for immediate recognition and increased understanding of rapidly changing clinical situations to help clinicians make better decisions.The Next Perspective on Guiding Volume Administration.
The EV1000 clinical platform offers the next perspective in guiding volume administration.
The latest visual clinical support screens available on the EV1000 clinical platform – for use with the ClearSight, FloTrac and VolumeView systems – enable you to maintain your patients in the optimal volume range and reduce volume administration variability. Time-in-Target indicator facilitates Perioperative Goal-Directed Therapy (PGDT) compliance, helping the user to track and manage key parameters, and create and monitor customized protocols. The Time-in-Target indicator represents the accumulated percentage of time a parameter has been within target range during an active tracking session.
Downloadable, off-line PGDT analytics software offers additional monitoring dashboards and robust reporting features for
EV1000 Clinical Platform Product Specifications
|Dimensions||Height: 226 mm
Width: 296 mm
Depth: 58.6 mm
|Display||Active Area: 257 mm (10.4")
Resolution: 800 x 600 LCD
|Operating System||Windows XPe|
|Monitor (Advantech Model)|
|Weight||2 kg (4.4 lbs)|
|Dimensions||Height: 217 mm
Width: 280 mm
Depth: 46 mm
|Display||Active Area: 266 mm (10.4")
Resolution: 1024 x 768 LCD
|Operating System||Windows XPe|
|Dimensions||Height: 145 mm
Width: 206 mm
Depth: 64 mm
EV1000 Clinical Platform Accessories
|EV1000 System||Model Number|
|EV1000 Clinical Platform||EV1000A|
|EV1000 Monitor||Model Number|
|EV1000 Databox||Model Number|
|Databox Monitor Bracket||EVBB1|
|EV1000 Pump-Unit||Model Number|
|EV1000 Noninvasive Peripheral Hardware||Model Number|
|Pressure Controller Kit||PC2K|
|Pressure Controller Band Multi Pack||PC2B|
|Pressure Controller Cuff Connector Cap||PC2CCC|
|Heart Reference Sensor||EVHRS|
The EV1000 clinical platform provides the choice of parameters you want to view and how you want to view them. Screen options include the real-time physiology screen (both intermittent and continuous), the cockpit screen, the goal positioning screen, graphical trend screen and the physio-relationship screen.
Advanced hemodynamic parameters, when implemented within a perioperative goal-directed therapy (PGDT) protocol, are demonstrated to reduce post-surgical complications in moderate to high-risk surgery patients.16 The FloTrac system provides advanced hemodynamic parameters that can be used in PGDT to control variability in volume administration and help you maintain your patient in the optimal volume range.
- Stroke Volume Optimization (SV)1–9
Stroke volume measurement with the FloTrac sensor enables an individualized approach for administering fluid until SV reaches a plateau on the Frank-Starling curve, to prevent hypovolemia and excessive fluid administration.
- Stroke Volume Variation Optimization (SVV)10
For control-ventilated patients, SVV has proved to be a highly sensitive and specific indicator for pre-load responsiveness, serving as an accurate marker of patient status on the Frank-Starling curve.
30+ randomized controlled trials and 14+ meta-analyses have demonstrated clinical benefits of hemodynamic optimization over traditional volume management.12-15
Advanced hemodynamic parameters, when implemented within a PGDT protocol, are demonstrated to reduce postsurgical complications in moderate to high-risk surgery patients.16 The FloTrac system provides advanced hemodynamic parameters that can be used in PGDT to control variability in volume administration and help you maintain your patient in the optimal volume range.
In the critically ill, traditional vital signs may be late indicators of compromised or inadequate oxygen delivery to the tissues. By providing a real-time, global measure of oxygen balance, the Edwards oximetry central venous catheter detects critical changes earlier than traditional vital signs – enabling you to detect and prevent tissue hypoxia sooner.18-22
Continuous ScvO2 monitoring is key to assessing the adequacy of the balance of oxygen delivery and consumption. The goal of continuous ScvO2 monitoring with the Edwards oximetry central venous catheter is to bring into balance the relationship between oxygen delivery and consumption to help improve the care of high-acuity patients.26
Continuous ScvO2 monitoring has multiple applications in the intra- and post-op stages,28,29 including:
- Risk for high blood loss, such as hepatic resections, trauma, vascular cases
- High fluid shifts in gastrointestinal cases
- Toleration of single-lung ventilation in thoracic procedures
- Early indication of failure to tolerate extubation
The prognostic value of ScvO2 has been demonstrated in19:
- Post-op high-risk surgeries31
- Cardiac failure in CHF26,30
- Recovery in cardiac arrest24,25
The VolumeView set from Edwards Lifesciences in combination with EV1000 clinical platform enables the display of valuable volumetric parameters in an entirely new, meaningful way.
Delivered via the EV1000 clinical platform's Visual Clinical Support, the VolumeView set is able to offer you a unique, clear, visual depiction of patient physiologic status—including extravascular lung water (EVLW).
Intended for use in treating your acutely ill patients, the VolumeView set provides informative volumetric parameters (EVLW, PVPI, GEDV and GEF) that can be used specifically in the treatment of pulmonary edema, acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) 33. The volumetric parameters are provided via transpulmonary thermodilution (TPTD).
The VolumeView set also provides valuable, continuous, calibrated hemodynamic parameters (CO, SV, SVR, and SVV) via a patented Edwards proprietary VolumeView algorithm. This algorithm provides continuous trending between calibrations of these key hemodynamic parameters based upon shape variables. These parameters can also be calibrated through manual, intermittent transpulmonary thermodilution.
Edwards has been providing science-based education since 1972. We offer a full range of on-line, in-print and on-site programs that are available to your clinicians or staff.
Following are relevant educational tools:
EV1000 Clinical Platform and FloTrac Sensor Setup
In-service training video highlighting how to properly set up the FloTrac sensor with the EV1000 clinical platform.
EV1000 Clinical Platform and ClearSight Finger Cuff Setup
In-service training video highlighting how to properly set up the ClearSight finger cuff with the EV1000 clinical platform.
EV1000 Clinical Platform and Edwards Oximetry Central Venous Catheter Setup
In-service training video highlighting how to properly set up the Edwards oximetry central venous catheter with the EV1000 clinical platform.
The Edwards Advantage
We are committed to providing your institution, clinicians and staff with the highest levels of customer service and support to ensure seamless product implementation and ongoing use:
- Technical Support – Simply call +8001 8001 801 or email email@example.com
Contact a Sales Representative
Do you have feedback about our products? Click here
- Cecconi M, Fasano N, Langiano N, et al. Goal directed haemodynamic therapy during elective total hip arthroplasty under regional anaesthesia. Crit Care. 2011;15:R132
- Sinclair S, James S, Singer M. Intraoperative intravascular volume optimization and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. AMJ. 1997;315:909–912.
- Gan T, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97(4):820–826.
- Venn R, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88(1):65–71.
- Conway D, Mayall R, Abdul-Latif M, Gilligan S, Tackaberry C. Randomised controlled trial investigating the influence of intravenous fluid titration using oesophageal Doppler monitoring during bowel surgery. Anaesthesia. 2002;57(9):845–849.
- McKendry M, McGloin H, Saberi D, Caudwell L, Brady A, Singer M. Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery. BMJ. 2004;329:358.
- Wakeling H, McFall M, Jenkins C, Woods W, Barclay G, Fleming S. Intraoperative oesophageal Doppler-guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005;95(5):634–642
- Noblett S, Snowden C, Shenton B, Horgan A. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. BJS. 2006;93(9):1069–1076.
- ChytraI, Pradl R, Bosman R, Pelnar P, Kasal E, Zidkova A. Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients: a randomized controlled trial. Crit Care. 2007;11:R24.
- Benes J, ChytraI, Altmann P, et al. Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care. 2010;14:1-15.
- Donati A, Loggi S, Preiser JC, Orsetti G, Munch C, Gabbanelli V, Pelaia P, Pietropaoli P. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Chest. 2007;132:1817–1824.
- Grocott et al. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane systematic review. Br J Anaesth 2013
- Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth 2009; 103: 637–46
- Dalfino L, Giglio MT, Puntillo F, Marucci M, Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and meta-analysis. Crit Care 2011; 15: R154
- Corcoran T et al. Perioperative Fluid Management Strategies in Major Surgery: A Stratified Meta-Analysis. Anesthesia – Analgesia 2012
- Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high risk surgical patients. Anesthesia – Analgesia 2011; 112: 1392–402.
- Bellamy, MC. Wet, dry or something else? B J Anaestha. 2006; 97(6): 755–757
- Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-8.
- Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001;7(3):204-11.
- Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol. 2002;68(4):226-30.
- Scalea, TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30(12):1539-43.
- Ander, DS, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998;82(7):888-91.
- Rady, MY, et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14(2):218-25.
- Nakazawa, K, et al. Usefulness of central venous oxygen saturation monitoring during cardiopulmonary resuscitation. A comparative case study with end-tidal carbon dioxide monitoring. Intensive Care Med 1994;20(6):450-1.
- Rivers, EP, et al. The clinical implications of continuous central venous oxygen saturation during human CPR. Ann Emerg Med 1992;21(9):1094-101.
- Loren D. Continuous venous oximetry in surgical patients. Ann Surg. 1986;203/3:329-333.
- Donati A, et al. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk patients. Chest. 2007;132:1817-1824.
- Noguiera P, et al. Central Venous Saturation: A Prognostic Tool in Cardiac Surgery Patients. J Intensive Care Med. 2010;25(2):111-116.
- Vallet B, et al. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 2010;14:213.
- Edwards, Vigileo Operators Manual: A-4.
- Pearse, R, et al. Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005;9(6):R694-91.
- CL Gurudatt. Perioperative fluid therapy: How much is not too much? Indian J Anaesth. 2012 Jul-Aug: 56(4): 323-®325
- Monet et al. Assessing pulmonary permeability by transpulmonary thermodilution allows differentiation of hydrostatic pulmonary edema from ALI/ARDS. Intensive Care Med, 2007;33:448-453